Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population

(1) Background: Lysyl oxidase (LOX) plays a dual role in carcinogenesis and studies show a higher risk of cancer in LOX G473A variants. The present study evaluated the pattern of LOX G473A polymorphism (rs1800449) and serum LOX levels in ovarian cancer patients. (2) Methods: Serum LOX levels were es...

Full description

Bibliographic Details
Main Authors: Suchitra Kumari, A. Raj Kumar Patro, Baijayantimala Mishra, Saubhagya Kumar Jena, Sweta Singh
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/1/53
_version_ 1797494808909971456
author Suchitra Kumari
A. Raj Kumar Patro
Baijayantimala Mishra
Saubhagya Kumar Jena
Sweta Singh
author_facet Suchitra Kumari
A. Raj Kumar Patro
Baijayantimala Mishra
Saubhagya Kumar Jena
Sweta Singh
author_sort Suchitra Kumari
collection DOAJ
description (1) Background: Lysyl oxidase (LOX) plays a dual role in carcinogenesis and studies show a higher risk of cancer in LOX G473A variants. The present study evaluated the pattern of LOX G473A polymorphism (rs1800449) and serum LOX levels in ovarian cancer patients. (2) Methods: Serum LOX levels were estimated by enzyme linked immunosorbent assay (ELISA). A polymorphism of rs1800449 of LOX gene was detected by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Selected samples were sequenced for external validation. (3) Results: A majority of study participants were from low socio-economic status. Serum LOX level was significantly higher in ovarian cancer patients as compared to control. Serum LOX level in early-stage ovarian cancer was significantly lower as compared to advanced stage (FIGO stage III & IV). Wild type GG genotype was used as reference. Genotypes AA were associated with a significant risk of epithelial ovarian cancer (OR 3.208; <i>p</i> value- 0.033). A allele of rs1800449 polymorphism of LOX gene, the odds ratio was 1.866 (95% Confidence Interval 1.112–3.16) <i>p</i> value = 0.017 (4) Conclusions: A allele of rs1800449 polymorphism of LOX gene presents an increased risk of ovarian cancer in East Indian population. Serum LOX levels could be a potential biomarker for the diagnosis and prognosis of ovarian cancer.
first_indexed 2024-03-10T01:39:37Z
format Article
id doaj.art-ace28aa44fd34ca895e223e3e5a64c41
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T01:39:37Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-ace28aa44fd34ca895e223e3e5a64c412023-11-23T13:27:25ZengMDPI AGDiagnostics2075-44182021-12-011215310.3390/diagnostics12010053Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian PopulationSuchitra Kumari0A. Raj Kumar Patro1Baijayantimala Mishra2Saubhagya Kumar Jena3Sweta Singh4Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar 751019, IndiaMolecular Biology Laboratory, Department of Microbiology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar 751024, IndiaDepartment of Microbiology, All India Institute of Medical Sciences, Bhubaneswar 751019, IndiaDepartment of Obstetrics & Gynaecology, All India Institute of Medical Sciences, Bhubaneswar 751019, IndiaDepartment of Obstetrics & Gynaecology, All India Institute of Medical Sciences, Bhubaneswar 751019, India(1) Background: Lysyl oxidase (LOX) plays a dual role in carcinogenesis and studies show a higher risk of cancer in LOX G473A variants. The present study evaluated the pattern of LOX G473A polymorphism (rs1800449) and serum LOX levels in ovarian cancer patients. (2) Methods: Serum LOX levels were estimated by enzyme linked immunosorbent assay (ELISA). A polymorphism of rs1800449 of LOX gene was detected by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Selected samples were sequenced for external validation. (3) Results: A majority of study participants were from low socio-economic status. Serum LOX level was significantly higher in ovarian cancer patients as compared to control. Serum LOX level in early-stage ovarian cancer was significantly lower as compared to advanced stage (FIGO stage III & IV). Wild type GG genotype was used as reference. Genotypes AA were associated with a significant risk of epithelial ovarian cancer (OR 3.208; <i>p</i> value- 0.033). A allele of rs1800449 polymorphism of LOX gene, the odds ratio was 1.866 (95% Confidence Interval 1.112–3.16) <i>p</i> value = 0.017 (4) Conclusions: A allele of rs1800449 polymorphism of LOX gene presents an increased risk of ovarian cancer in East Indian population. Serum LOX levels could be a potential biomarker for the diagnosis and prognosis of ovarian cancer.https://www.mdpi.com/2075-4418/12/1/53lysyl oxidasesingle nucleotide polymorphismrestriction fragment length polymorphismovarian cancer
spellingShingle Suchitra Kumari
A. Raj Kumar Patro
Baijayantimala Mishra
Saubhagya Kumar Jena
Sweta Singh
Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
Diagnostics
lysyl oxidase
single nucleotide polymorphism
restriction fragment length polymorphism
ovarian cancer
title Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
title_full Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
title_fullStr Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
title_full_unstemmed Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
title_short Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
title_sort serum lysyl oxidase levels and lysyl oxidase gene polymorphism in ovarian cancer patients of eastern indian population
topic lysyl oxidase
single nucleotide polymorphism
restriction fragment length polymorphism
ovarian cancer
url https://www.mdpi.com/2075-4418/12/1/53
work_keys_str_mv AT suchitrakumari serumlysyloxidaselevelsandlysyloxidasegenepolymorphisminovariancancerpatientsofeasternindianpopulation
AT arajkumarpatro serumlysyloxidaselevelsandlysyloxidasegenepolymorphisminovariancancerpatientsofeasternindianpopulation
AT baijayantimalamishra serumlysyloxidaselevelsandlysyloxidasegenepolymorphisminovariancancerpatientsofeasternindianpopulation
AT saubhagyakumarjena serumlysyloxidaselevelsandlysyloxidasegenepolymorphisminovariancancerpatientsofeasternindianpopulation
AT swetasingh serumlysyloxidaselevelsandlysyloxidasegenepolymorphisminovariancancerpatientsofeasternindianpopulation